Insider Transactions in Q1 2024 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Sung Lee EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,008
-5.64%
|
$54,072
$9.89 P/Share
|
|
Feb 26
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
17,722
-13.56%
|
$194,942
$11.65 P/Share
|
|
Feb 22
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,028
-7.13%
|
$100,280
$10.05 P/Share
|
|
Feb 22
2024
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,568
-5.5%
|
$145,680
$10.05 P/Share
|
|
Feb 22
2024
|
Sung Lee EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.3%
|
-
|
|
Feb 22
2024
|
Marianne De Backer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+18.89%
|
-
|
|
Feb 22
2024
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
12,296
-8.36%
|
$122,960
$10.05 P/Share
|
|
Feb 22
2024
|
Ann M. Hanly EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+18.1%
|
-
|
|
Feb 20
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
16,872
-10.7%
|
$168,720
$10.22 P/Share
|
|
Feb 16
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,878
-6.46%
|
$108,780
$10.24 P/Share
|
|
Feb 16
2024
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,321
-1.24%
|
$33,210
$10.24 P/Share
|
|
Jan 02
2024
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+9.74%
|
$80,000
$1.32 P/Share
|